The overarching goal of this ICBG is to improve human health and well being through an integrated set of programs dedicated to the description, assessment, rational utilization, and conservation of biodiversity in Papua New Guinea (PNG). PNG is home to approximately 5% of the world's biodiversity. An understanding of the range of biological resources existing in PNG is essential for their management, for the preservation of species critical to indigenous cultures, and for the development of strategies for sustainable use. Our central hypothesis is that effective new therapeutics can be derived from the natural products of PNG's biological wealth. Such therapeutics can provide needed revenue to local stake-holders and responsible PNG institutions, and an incentive for the preservation of biological diversity. The university-based drug discovery component will focus on human immunodeficiency virus and Mycobacterium tuberculosis, while the industry based drug discovery component will focus on parasitic diseases, animal health and other therapeutic targets. The source organisms for drug discovery will be marine and terrestrial microbes and marine invertebrate animals. Documentation and preservation of traditional knowledge concerning medicinal plant use in PNG will be a second emphasis of this work. Medicinal plant surveys will be complemented by projects in support of the Traditional Medicines Taskforce, and student theses, to provide pharmacologic validation and chemical standardization of medicinal plants, and the identification of novel bioactive molecules. This research will provide professional development, educational opportunities and technology transfer for collaborating scientists and students. Conservation and biodiversity studies will center in the CTFS/SIGEO forest dynamics plot that has been established in Wanang, PNG, as part of the previous grant cycle's achievements. This plot is a unique and powerful research tool for studying forest dynamics, carbon sequestration and climate effects. Plot activities will integrate the botanical survey with the ecosystem study to include soil microbes and small plants. Outreach activities conducted as part of the Traditional Medicines and botanical survey work will foster the conservation and sustainable use of resources and provide benefits to stake-holders. Legislative initiatives developed with government input promote scientific exchange, conservation and sustainable resource use.

Public Health Relevance

This research will discover new natural products from marine and terrestrial organisms from Papua New Guinea with activity against HIV, TB and parasitic diseases. Documentation of the medicinal and economic value of indigenous organisms will provide incentive for conservation of ecosystems in PNG and new healthcare options to domestic and foreign sufferers of these infectious diseases.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Project--Cooperative Agreements (U01)
Project #
3U01TW006671-10S1
Application #
8850600
Study Section
Program Officer
Katz, Flora N
Project Start
2014-07-01
Project End
2015-05-31
Budget Start
2014-07-01
Budget End
2015-05-31
Support Year
10
Fiscal Year
2014
Total Cost
$400,000
Indirect Cost
$116,595
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Smith, Thomas E; Pond, Christopher D; Pierce, Elizabeth et al. (2018) Accessing chemical diversity from the uncultivated symbionts of small marine animals. Nat Chem Biol 14:179-185
Vincent, J B; Weiblen, G D; May, G (2016) Host associations and beta diversity of fungal endophyte communities in New Guinea rainforest trees. Mol Ecol 25:825-41
Prosser, Sean W J; deWaard, Jeremy R; Miller, Scott E et al. (2016) DNA barcodes from century-old type specimens using next-generation sequencing. Mol Ecol Resour 16:487-97
Larson, Erica C; Pond, Christopher D; Rai, Prem P et al. (2016) Traditional Preparations and Methanol Extracts of Medicinal Plants from Papua New Guinea Exhibit Similar Cytochrome P450 Inhibition. Evid Based Complement Alternat Med 2016:7869710
Martins, Laura J; Bonczkowski, Pawel; Spivak, Adam M et al. (2016) Modeling HIV-1 Latency in Primary T Cells Using a Replication-Competent Virus. AIDS Res Hum Retroviruses 32:187-93
Kakule, Thomas B; Jadulco, Raquel C; Koch, Michael et al. (2015) Native promoter strategy for high-yielding synthesis and engineering of fungal secondary metabolites. ACS Synth Biol 4:625-33
Larson, Erica C; Hathaway, Laura B; Lamb, John G et al. (2014) Interactions of Papua New Guinea medicinal plant extracts with antiretroviral therapy. J Ethnopharmacol 155:1433-40
Kwon, Ki-Hyeok; Serrano, Catherine M; Koch, Michael et al. (2014) Synthesis of bicyclic guanidines via cascade hydroamination/Michael additions of mono-N-acryloylpropargylguanidines. Org Lett 16:6048-51
Jadulco, Raquel C; Koch, Michael; Kakule, Thomas B et al. (2014) Isolation of pyrrolocins A-C: cis- and trans-decalin tetramic acid antibiotics from an endophytic fungal-derived pathway. J Nat Prod 77:2537-44
Lu, Zhenyu; Van Wagoner, Ryan M; Pond, Cristopher D et al. (2014) Myristicyclins A and B: antimalarial procyanidins from Horsfieldia spicata from Papua New Guinea. Org Lett 16:346-9

Showing the most recent 10 out of 23 publications